BioSpace News Archive

75% of patients with relapsing-remitting multiple sclerosis (RRMS) and suboptimal response to prior treatment had no evidence of disease activity two years after switching to Ocrevus in open-label Phase IIIb CASTING study

AI and ML are virtually penetrating almost all industries, including healthcare. These technologies are generating incremental opportunities for companies in the breast imaging market.

According to Transparency Market Research’s latest report on the global dental Consumables market for the historical period 2017–2018 and forecast period 2019–2027, rise in dental tourism, advancements in dental implant techniques, and rising incidence of dental problems are driving the global market during the forecast period.

Transparency Market Research has published a new report titled, ‘Diabetes Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

Transparency Market Research has published a new report titled, ‘Global Dry Eye Disease Treatment Market.’ According to the report, the global dry eye disease treatment market was valued at ~US$ 5.4 Bn in 2019 and is projected to expand at a CAGR of ~4% from 2020 to 2030.

Electronic clinical outcome assessment is an umbrella term encompassing patient-reported outcomes, observer-reported outcomes, clinician-reported outcomes, and performance-related outcomes.

TLC announced that George Yeh, President of TLC, will be discussing recent activities regarding the company in a fireside chat with Kristen Kluska, Research Analyst, at Cantor Virtual Global Healthcare Conference on Tuesday, September 15, 2020 at 10:00am ET.

Cancer Prevention Pharmaceuticals, Inc. announced The New England Journal of Medicine has published results from its landmark FAP-310 Phase 3 clinical trial of CPP-1X/sul as a pharmaco-preventive treatment for adults with familial adenomatous polyposis.

Nearly two-thirds of U.S. physicians report intensifying levels of burnout and increased feelings of loneliness during the pandemic, according to the results of a new report from Medscape.

United Therapeutics Corporation announced the appointment of Linda Maxwell, M.D. to its Board of Directors as an independent director, effective as of September 10, 2020.